Clinical Trial Update: Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of AJU-S56 for dry eye syndrome has completed, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• AJU-S56

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED